✦ LIBER ✦

1471 PROSPECTIVE CLINICAL TRIAL TO EVALUATE MARKERS OF RESPONSE TO INTRAVESICAL THERAPY FOR BLADDER CANCER: PRELIMINARY RESULTS

✍ Scribed by Messetti, Fabrizio; Anderson, Roosevelt; Martinez, Shanna; Nogueras Gonzalez, Graciela; Katz, Ruth; Khanna, Abha; Grossman, H. Barton; Dinney, Colin; Kamat, Ashish

Book ID: 122765723
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 44 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.02.1186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of Fluorescence In Situ Hybridizatio

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial

✍ Kamat, Ashish M.; Dickstein, Rian J.; Messetti, Fabrizio; Anderson, Roosevelt; P 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 606 KB

1771 TREATMENT WITH INTRACUTANEOUS AND I

1771 TREATMENT WITH INTRACUTANEOUS AND INTRAVESICAL KEYHOLE LIMPET HEMOCYANIN IS INFERIOR TO INTRAVESICAL MITOMYCIN-C FOR PREVENTION OF RECURRENCES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE III TRIAL

✍ Lammers, Rianne J.M.; Witjes, Wim P.J.; Janzing-Pastors, Maria H.C.; Caris, Chri 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB

The 9 months clinical response to intrav

The 9 months clinical response to intravesical BCG-therapy as a predictive factor for progression in patients with T1 superficial bladder cancer: report of 228 patients

✍ Sataa Sallami; Imed Kbaier; Meher Chtourou; Ali Horchani 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB